Allen B. Chefitz
YOU?
Author Swipe
View article: Point-of-Care No-Specimen Diagnostic Platform Using Machine Learning and Raman Spectroscopy: Proof-of-Concept Studies for Both COVID-19 and Blood Glucose
Point-of-Care No-Specimen Diagnostic Platform Using Machine Learning and Raman Spectroscopy: Proof-of-Concept Studies for Both COVID-19 and Blood Glucose Open
Significance: We describe a novel, specimen-free diagnostic platform that can immediately detect both a metabolite (glucose) or an infection (COVID-19) by non-invasively using Raman spectroscopy and machine learning. Aim: Current diagnosti…
View article: Point-of-Care No-Specimen Diagnostic Platform using Machine Learning and Raman Spectroscopy: Proof-of-Concept Studies for Both COVID-19 and Blood Glucose
Point-of-Care No-Specimen Diagnostic Platform using Machine Learning and Raman Spectroscopy: Proof-of-Concept Studies for Both COVID-19 and Blood Glucose Open
Significance We describe a novel, specimen-free diagnostic platform that can immediately detect both a metabolite (glucose) or an infection (COVID-19), by non-invasively using Raman spectroscopy and machine learning. Aim Current diagnostic…
View article: Raman spectroscopy, used transcutaneously and non-invasively from a finger, to predict COVID-19: A feasibility, proof-of-concept study
Raman spectroscopy, used transcutaneously and non-invasively from a finger, to predict COVID-19: A feasibility, proof-of-concept study Open
BACKGROUND A definitive COVID-19 infection typically is diagnosed by laboratory tests, including real-time, reverse-transcriptase Polymerase Chain Reaction (PCR)-based testing. These currently available COVID-19 tests require the patient t…